Press release
E-prescribing Market Growth, Size, Opportunities, Trends, Regional Overview, Leading Company Analysis, And Key Country Forecast to 2032
E-prescribing, also known as electronic prescribing, is the computer-based, electronic generation and transmission of a medication prescription, taking the place of paper and faxed prescriptions. The terms e-prescribing and e-Rx refer to the electronic prescribing of medications. When prescriptions are electronically transmitted using computer technology, it is possible to automatically check for drug-drug and drug-allergy interactions. In addition, e-prescribing can help to reduce medication errors, such as wrong dosage, wrong medication, and wrong patient.E-prescribing systems are web-based applications that link a prescriber, typically a physician, to a pharmacy. The systems allow the prescriber to electronically send a prescription to a pharmacy. The pharmacy receives the prescription electronically and can dispense the medication to the patient. In some cases, the patient can also request a refill of their prescription electronically.
Download Sample PDF Of This Report:
https://www.globalinsightservices.com/request-sample/GIS24489/?utm_id=1018
Key Trends
There are several key trends in e-prescribing technology. One is the use of electronic health records (EHRs). EHRs can help physicians keep track of patients' medications and allergies, as well as laboratory results.
Another trend is the use of clinical decision support tools. These tools can help physicians make better prescribing decisions by providing them with information about drug interactions and allergies.
Finally, many e-prescribing systems now allow patients to request refills online. This can improve patient convenience and satisfaction.
Key Drivers
PBMs and health plans can gain greatly from e-prescribing. Studies have shown that higher formulary adherence, better medication utilisation reviews, and fewer mistakes when the prescription claim is adjudicated can result in lower drug expenditures and improved plan performance. Because fewer prior authorizations are required when the medication formulary is taken into consideration at the time of prescription, PBMs gain from the administrative process' simplicity. If PBMs or health plans are able to offer feedback at the moment of prescription, such as a patient's previous claim history from other prescribers, there may be chances in the future to improve medication utilisation. Payors that use PBMs and health plans to manage their pharmacy benefit, including employers, can receive savings from reduced administrative costs and better medication use. PBMs and health plans can also use e-prescription software to create electronic guidance, or clinical decision support systems, which incentivizes physicians to adhere to accepted prescribing practices.
Request Customization:
https://www.globalinsightservices.com/request-customization/GIS24489/?utm_id=1018
Market Segments
The E-prescribing Market has been segmented into Component, Delivery Mode, Usage Methods, Substances, Specialties, End User, and Region. Based on the Component, the E-prescribing market is segmented into Hardware, Systems & Solutions, and Services. Further, the Systems & Solutions segment is bifurcated into Integrated Solutions and Standalone Solutions. Similarly, the Services segment is sub-segmented into Support & Maintenance Services, Implementation Services, Training & Education Services, and Network Services. On the basis of Delivery Mode, the market is bifurcated into Web/Cloud-Based and On-premise. Based on Usage Methods, the market is bifurcated into Handheld and Computer Based Devices. On the basis of Substances, the market is classified into Controlled Substances and Non-controlled Substances. Based on Specialties, the market is segmented into Oncology, Sports Medicine, Neurology, Cardiology, and Others. On the basis of End User, the market is segmented into Hospital, Office-based Physicians, and Pharmacy. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and the Rest of the World.
Key Players
Some of the key players of E-prescribing market are Ashtons (UK), AdvancedMD, Inc. (US), Cerner (Oracle Corporation) (US), Chetu Inc. (US), DrFirst.com, Inc. (US), iCoreConnect (US), Networking Technology, Inc. (RXNT) (US), NXGN Management, LLC (US), Office Ally, Inc. (US), Optum, Inc. (US), Practice Fusion, Inc. (US), Surescripts, LLC (US), Tebra Technologies, Inc. (formerly known as Kareo, Inc.) (US), Veradigm LLC (US), and Wolters Kluwer N.V. (Netherlands).
Procure Complete Report (PDF with Insights, Charts, Tables, and Figures)
https://www.globalinsightservices.com/checkout/single_user/GIS24489/?utm_id=1018
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release E-prescribing Market Growth, Size, Opportunities, Trends, Regional Overview, Leading Company Analysis, And Key Country Forecast to 2032 here
News-ID: 3332654 • Views: …
More Releases from Global Insight Services

Immuno Oncology Drugs Market Projected to Reach $634.1 Billion by 2034, Growing …
The Immuno Oncology Drugs Market is rapidly emerging as a transformative segment in the global healthcare industry. These drugs harness the body's immune system to identify and attack cancer cells, offering innovative treatment alternatives to traditional chemotherapy and radiation therapies. Immuno-oncology therapies include monoclonal antibodies, checkpoint inhibitors, cancer vaccines, and cell-based therapies such as CAR-T cells. The growth of this market is primarily driven by advancements in biotechnology, an improved…

GLP 1 Market Projected to Reach $221.8 Billion by 2034, Growing at 9% CAGR | Ove …
The GLP 1 Market is experiencing unprecedented growth, fueled by the rising prevalence of type 2 diabetes and obesity globally. GLP-1, or glucagon-like peptide-1 receptor agonists, represents a groundbreaking therapeutic class that improves insulin secretion, reduces glucagon production, and slows gastric emptying. These mechanisms not only enhance glycemic control but also support weight management, making GLP-1 therapies a preferred choice among healthcare providers and patients alike. Over the years, the…

Autonomous Bus Market to Expand to $11.6 Billion by 2034, Advancing at 18.8% CAG …
Market Overview
Autonomous Bus Market is revolutionizing the future of urban mobility through advanced automation technologies. Valued at $2.1 billion in 2024, the market is projected to reach $11.6 billion by 2034, expanding at a strong CAGR of 18.8%. This market focuses on the development and deployment of self-driving buses equipped with cutting-edge sensors, artificial intelligence, and vehicle-to-everything (V2X) communication systems. These buses are designed to improve road safety, enhance passenger…

Automotive Tire Market to Attain $976.7 Billion by 2034, Growing at 9.2% CAGR | …
Market Overview
Automotive Tire Market is experiencing remarkable growth as the industry embraces innovation, sustainability, and digital transformation. Valued at $406 billion in 2024, the market is projected to soar to $976.7 billion by 2034, reflecting a CAGR of 9.2%. This expansion is primarily driven by the surge in global vehicle production, growing consumer preference for durable and high-performance tires, and the increasing adoption of smart tire technologies. The Automotive Tire…
More Releases for PBMs
Pharmacy Benefit Manager Market to Expand at 6.5% CAGR, Reaching US$ 1,050 Bn by …
The Pharmacy Benefit Manager (PBM) market plays a critical role in the healthcare ecosystem, primarily serving as an intermediary between insurers, pharmacies, and drug manufacturers to optimize prescription drug benefits for consumers. PBMs manage prescription drug programs for health insurers, working to reduce costs by negotiating discounts and rebates from pharmaceutical companies and pharmacies. With increasing healthcare expenditures globally and rising drug prices, PBMs are becoming increasingly essential in controlling…
Pharmacy Benefit Manager Market Expected to Reach USD 1,050 Billion by 2032 - Pe …
Market Overview
The global Pharmacy Benefit Manager (PBM) market is on a robust growth trajectory, with a projected Compound Annual Growth Rate (CAGR) of 7.5%. According to Persistence Market Research, the market size is expected to rise from USD 632.9 billion in 2024 to USD 1,050 billion by 2032. PBMs act as intermediaries between insurance companies, pharmacies, and drug manufacturers, focusing on managing prescription drug benefits to reduce costs and enhance…
Robust Growth in Medication Benefits Administration Market (2024-2031): Industry …
The worldwide "Medication Benefits Administration Market" 2024 Research Report presents a professional and complete analysis of the Global Medication Benefits Administration Market in the current situation. This report includes development plans and policies along with Medication Benefits Administration manufacturing processes and price structures. the reports 2024 research report offers an analytical view of the industry by studying different factors like Medication Benefits Administration Market growth, consumption volume, Market Size, Revenue,…
Pharmacy Benefit Management Market Poised for USD 882 Billion Boom by 2031, Driv …
The global pharmacy benefit management market, estimated at USD 553.49 billion in 2023, is poised for substantial growth, reaching USD 882.86 billion by 2031. This significant expansion, at a compound annual growth rate (CAGR) of 6.01% over the forecast period from 2024 to 2031, is driven by rising healthcare costs, the increasing prevalence of chronic diseases, and the growing demand for cost-effective medication management solutions.
Pharmacy benefit management involves the administration…
Future Growth: Medication Benefits Administration Market Sees Promising Growth i …
The latest research study released by Worldwide Market Reports on "Medication Benefits Administration Market 2024" holds tons of experience in offering comprehensive and accurate analysis of global as well as regional markets. The analysts and researchers authoring the report have provided a deeper competitive analysis of the Medication Benefits Administration market along with exhaustive company profiling of leading market players. This research study of the Medication Benefits Administration Market involved…
Pharmacy Benefit Management Market Is Driven by the Rising Expense of Healthcare …
Pharmacy Benefit Management (PBM) is a third-party administrator of prescription drug programs for commercial health plans, self-insured employer groups, unions, government employee groups, and managed care organizations. PBMs are responsible for developing and maintaining the formulary, negotiating discounts and rebates with drug manufacturers, and processing and paying prescription drug claims. They also provide drug utilization review, mail order pharmacy services, and specialty pharmacy services.
Download Sample PDF Of This Report:
https://www.globalinsightservices.com/request-sample/GIS22088/?utm_id=1018
Key Trends
Pharmacy…